It is intended to provide a novel drug which exhibits an excellent effect of preventing HIV infection in transfusing blood and using a blood preparation. This object can be achieved by a preventive for HIV infection in transfusing blood and using a blood preparation characterized by containing a compound having antagonism to a CC chemokine receptor (preferably antagonism to CCR5 and/or CCR2).
